Woman and Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
The primary objective of the study is to assess the efficacy of everolimus in patients with metastatic renal cell cancer whose disease progressed on or after prior first-line treatment with sunitinib or pazopanib. Efficacy will be measured by the rate of patients who are free of disease progression after 6 months of treatment with everolimus.
Inclusion criteria
- Metastatic Renal Cell Carcinoma